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A 66-year-old lady of Asian descent presented with
hypertension of 1-year duration, heart murmurs, and
hypercholesterolemia. She had frontal headaches, syncope,
and 10 lb weight loss over the past few months. Physical
examination revealed an elderly well-oriented lady in no
distress. Her pulse was 82 min1, blood pressure 140/90, neck
supple with no bruits or venous distention, skin showed no
rashes, lower limbs revealed no edema, cardiovascular
examination showed normal S1 and S2 with III/VI systolic
murmur heard over the left sternal border, lungs were clear to
auscultation, and abdomen was soft and non tender. Her
medications included an angiotensin-converting enzyme
inhibitor and a statin. Laboratory findings were significant
for a serum creatinine level of 1.3 mg per 100 ml, creatinine
clearance of 44 ml min1, and proteinuria (3.2 g 24 h1).
Lipid profile showed total cholesterol of 179 mg per
100 ml, triglycerides 84 mg per 100 ml, high-density lipo-
protein 37 mg per 100 ml, low-density lipoprotein 129 mg per
100 ml, and very-low-density lipoprotein 16.8 mg per 100 ml.
Remaining work up, including serologies, was negative.
A renal biopsy was performed to explain the proteinuria
and declining renal function.
RENAL BIOPSY
A total of 16 glomeruli were present, two of which were globally
sclerosed. Glomeruli showed distention and plugging of the
capillary loops by numerous periodic acid–Schiff-positive
amorphous ‘thrombus’-like material (Figure 1a and b). The
‘thrombi’ showed lamellations, did not polarize, and did not
stain for fibrin (red on trichrome). Immunofluorescence
microscopy was negative for immune deposits. Electron
microscopy showed that the thrombi consisted of lipid material
with vacuoles of different sizes (Figure 2). Foam cells were also
noted in some capillaries. The capillary walls showed thickening
and new basement membrane formation (double contours,
arrows), indicating endothelial injury and repair.
What is your diagnosis? What additional stain would help confirm the diagnosis?
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Figure 1 | Light microscopy showing lamellated ‘thrombus’-like
lipid material in the glomerular capillaries (a; periodic acid–Schiff
stain; b, Trichrome stain, original magnification  400).
Figure 2 | Electron microscopy showing lipid
material with numerous vacuoles of varying size within
the glomerular capillaries (original magnification
 7400); arrows indicate double contours.
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The Diagnosis | Lipoprotein glomerulopathy
DISCUSSION
The diagnosis of lipoprotein glomerulopathy is based on the
finding of lamellated lipid-like material within glomerular
capillaries by light microscopy; electron microscopy showed the
presence of lipid vacuoles of varying sizes within glomerular
capillaries. The lipid ‘thrombi’ are limited to the glomerulus.
Lipoprotein glomerulopathy on renal biopsy was confirmed
using immunohistochemical stains against apolipoprotein E
(Apo E) that stain the lipid ‘thrombi’ (Figure 3).
Lipoprotein glomerulopathy is a rare disease seen mostly
in patients of Asian ancestry. The patient typically presents
with hypertension and proteinuria; hematuria is rare. Renal
biopsy is required for diagnosis. The disease is associated
with mutations in the Apo E gene, resulting in elevated serum
Apo E levels. The disease can be confirmed by DNA
sequencing for Apo E mutations. Other systemic manifesta-
tions of hyperlipoproteinemia, such as xanthomas, corneal
arcus, and so on, are rare. Management is currently focused
toward intensive lipid lowering with statins and fibrates.
There is a high degree of recurrence of the disease in patients
treated with renal transplantation.1–3
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Figure 3 | Immunoperoxidase staining
showing positive staining of the thrombi for
Apo E lipoprotein within glomerular
capillaries.
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